Skip to main content
Livermore
Livermore
ZHEN

Centerpoint Advisors, LLC

SEC CIK
0001733788
Latest filing
Aug 5, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Centerpoint Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
545
Value
$43.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of HALO by Centerpoint Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026545$43.0K<0.1%00.0%UnchangedHolders
Q1 2026545$35.0K<0.1%−5−0.9%ReducedHolders
Q4 2025550$37.0K<0.1%00.0%UnchangedHolders
Q3 2025550$40.0K<0.1%00.0%UnchangedHolders
Q2 2025550$29.0K<0.1%00.0%UnchangedHolders
Q1 2025550$35.0K<0.1%00.0%UnchangedHolders
Q4 2024550$26.0K<0.1%00.0%UnchangedHolders
Q3 2024550$31.0K<0.1%00.0%UnchangedHolders
Q2 2024550$29.0K<0.1%00.0%UnchangedHolders
Q1 2024550$22.0K<0.1%00.0%UnchangedHolders
Q4 2023550$20.0K<0.1%−150−21.4%ReducedHolders
Q3 2023700$27.0K<0.1%00.0%UnchangedHolders
Q2 2023700$25.0K<0.1%00.0%UnchangedHolders
Q1 2023700$27.0K<0.1%00.0%UnchangedHolders
Q4 2022700$40.0K<0.1%−350−33.3%ReducedHolders
Q3 20221,050$42.0K<0.1%00.0%UnchangedHolders
Q2 20221,050$46.0K<0.1%00.0%UnchangedHolders
Q1 20221,050$42.0K<0.1%−50−4.5%ReducedHolders
Q4 20211,100$44.0K<0.1%00.0%UnchangedHolders
Q3 20211,100$45.0K<0.1%00.0%UnchangedHolders
Q2 20211,100$50.0K<0.1%00.0%UnchangedHolders
Q1 20211,100$46.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.